Table 1. .
Characteristics of Mobility Study Participants
|
Controls (n = 60) |
Glaucoma (n = 84) |
AMD (n = 47) |
|
| Demographics | |||
| Age, y (IQR)* | 69.4 (65.2–72.8) | 70.6 (66.4–74.5) | 75.1 (70.9–78.3)† |
| Non-white, % (n) | 23.3 (14) | 39.3 (33)† | 4.3 (2)† |
| Female, % (n) | 61.7 (37) | 53.6 (45) | 57.5 (27) |
| Education, y (IQR) | 16.5 (14–17) | 16 (14–17) | 16 (13–17) |
| Lives alone, % (n) | 18.3 (11) | 19.1 (16) | 21.3 (10) |
| Health | |||
| Comorbidities, n (IQR) | 2 (1–3) | 2 (1–3) | 2(1–3) |
| BMI, kg/m2 (IQR) | 27.9 (23.8–32.2) | 27.7 (24.5–32.0) | 28.3 (24.9–32.7) |
| Grip strength, kg force (IQR) | 26.3 (21.3–32.3) | 28.5 (21.6–36.3) | 26.3 (21.0–33.0) |
| Depressive symptoms, % (n) | 5 (3) | 6 (3) | 4.3 (2) |
| MMSE score (IQR) | 21 (20–22) | 21 (20–22) | 21 (20–22) |
| Vision | |||
| Better-eye MD, dB (IQR) | 0.17 (−0.65:0.9) | −8.0 (−16.7: −4.8)† | — |
| Better-eye VA, logMAR (IQR) | 0.08 (0–0.16) | 0.16 (0.1–0.3)† | 0.40 (0.2–0.7)† |
—
AMD patients did not have visual field testing.
*
Median (IQR) reported for continuous variables.
†
P < 0.05 in comparison of either glaucoma or AMD groups with controls.